Literature DB >> 10906408

Synthesis and structure-affinity relationships of 1,3, 5-alkylsubstituted cyclohexylamines binding at NMDA receptor PCP site.

A Jirgensons1, V Kauss, I Kalvinsh, M R Gold, W Danysz, C G Parsons, G Quack.   

Abstract

A series of 1,3,5-alkylsubstituted cyclohexylamines 2 were synthesized as ligands for the N-methyl-D-aspartate (NMDA) receptor phencyclidine (PCP) binding site. Pure diastereomers with defined configuration of amino group 2-ax and 2-eq were obtained. The optimal size of 1,3,5-substituents was determined for cyclohexylamines 2 with an equatorial amino group in the lowest energy conformation using Hansch analysis. According to the data, the lipophilic part of cyclohexylamines 2 does not discriminate between hydrophobic regions of the PCP binding site but rather recognizes this site as a whole lipophilic pocket.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906408     DOI: 10.1016/s0223-5234(00)00153-7

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  New Enantiomerically Pure Alkylimido Mo-Based Complexes. Synthesis, Characterization, and Activity as Chiral Olefin Metathesis Catalysts.

Authors:  Tatiana S Pilyugina; Richard R Schrock; Peter Müller; Amir H Hoveyda
Journal:  Organometallics       Date:  2007-01-20       Impact factor: 3.876

2.  Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.

Authors:  Eva Torres; María D Duque; Marta López-Querol; Martin C Taylor; Lieve Naesens; Chunlong Ma; Lawrence H Pinto; Francesc X Sureda; John M Kelly; Santiago Vázquez
Journal:  Bioorg Med Chem       Date:  2011-12-02       Impact factor: 3.641

3.  Structural Analysis, Molecular Modelling and Preliminary Competition Binding Studies of AM-DAN as a NMDA Receptor PCP-Site Fluorescent Ligand.

Authors:  Sethu Ndzibongwana; Samukelo Ngobese; Ahmad Sayed; Ciniso Shongwe; Simon White-Phillips; Jacques Joubert
Journal:  Molecules       Date:  2019-11-13       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.